Product Code: ETC4746735 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Serbia Influenza Vaccine Market is poised for steady growth rate improvements from 2025 to 2029. The growth rate starts at 6.77% in 2025 and reaches 7.95% by 2029.
The Influenza Vaccine market in Serbia is projected to grow at a growing growth rate of 7.40% by 2027, highlighting the country's increasing focus on advanced technologies within the Europe region, where Germany holds the dominant position, followed closely by United Kingdom, France, Italy and Russia, shaping overall regional demand.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Influenza Vaccine Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Influenza Vaccine Market - Industry Life Cycle |
3.4 Serbia Influenza Vaccine Market - Porter's Five Forces |
3.5 Serbia Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Serbia Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Serbia Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Serbia Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Serbia Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Serbia Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Serbia Influenza Vaccine Market Trends |
6 Serbia Influenza Vaccine Market Segmentations |
6.1 Serbia Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Serbia Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Serbia Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Serbia Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Serbia Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Serbia Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Serbia Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Serbia Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Serbia Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Serbia Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Serbia Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Serbia Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Serbia Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Serbia Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Serbia Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Serbia Influenza Vaccine Market Export to Major Countries |
7.2 Serbia Influenza Vaccine Market Imports from Major Countries |
8 Serbia Influenza Vaccine Market Key Performance Indicators |
9 Serbia Influenza Vaccine Market - Opportunity Assessment |
9.1 Serbia Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Serbia Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Serbia Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Serbia Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Serbia Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Serbia Influenza Vaccine Market - Competitive Landscape |
10.1 Serbia Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Serbia Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |